Skip to content

Nasdaq · CIK 0000704440

KRMD KORU Medical Systems, Inc.

Insider trading from SEC Form 4. Last filing 11 d ago. Close $2.96 on Oct 9, 2026, +1% from the 52-week low and -55% from the high.

Last 90 days

Net insider value
+$101k
more bought than sold
Buys
1
$101k by 1 insider
Sells
0
$0 by 0 insiders
Insiders on file
11
with a Form 4 at this company

Price and insider trades, last year

KRMDOct 9, 2026 · close 2.96

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at KORU Medical Systems, Inc., scored.

ScoreInsiderValueHoldingsPrice contextFiled
28WeakAdam R Kalbermatten
Chief Commercial Officer
buy
$101k
32,000 shares
+9%-

Transactions

The last 59 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Oct 1, 2026R John Fletcher
director, other
AGrant or award
Common Stock
+7,679$2.93$22k239,83611 d ago
Oct 1, 2026Robert Cascella
director
AGrant or award
Common Stock
+5,119$2.93$15k103,27411 d ago
Sep 30, 2026Joseph M. Manko Jr.
director, owner
AGrant or award
Common Stockindirect: By Horton Capital Partners Fund, LP
+5,119$0.00$05,074,66011 d ago
Oct 1, 2026Edward Wholihan
director
AGrant or award
Common Stock
+5,119$2.93$15k56,43111 d ago
Oct 1, 2026Donna French
director
AGrant or award
Common Stock
+5,119$2.93$15k103,63311 d ago
Oct 1, 2026Shahriar Matin
director
AGrant or award
Common Stock
+5,119$2.93$15k106,26311 d ago
Sep 8, 2026Adam R Kalbermatten
Chief Commercial Officer
POpen-market purchase
Common Stock
+32,000$3.16$101k394,01733 d ago
May 12, 2025Thomas Edward Adams
Chief Financial Officer
AGrant or award
Restricted Stock Unitsderivative
+32,773$0.00$032,773Aug 11, 2025
May 12, 2025Linda M Tharby
President and CEO
AGrant or award
Restricted Stock Unitsderivative
+55,911$0.00$055,911Aug 11, 2025
May 12, 2025Christopher Pazdan
Chief Operating Officer
AGrant or award
Restricted Stock Unitsderivative
+21,308$0.00$021,308Aug 11, 2025
Jul 28, 2025Adam R Kalbermatten
Chief Commercial Officer
AGrant or award
Common Stock
+300,000$0.00$0300,000Aug 11, 2025
May 12, 2025Linda M Tharby
President and CEO
AGrant or award
Restricted Stock Unitsderivative
+111,729$0.00$0111,729Aug 11, 2025
Aug 1, 2025Adam R Kalbermatten
Chief Commercial Officer
AGrant or award
Option to buy Common Stockderivative
+600,000$0.00$0600,000Aug 11, 2025
May 12, 2025Christopher Pazdan
Chief Operating Officer
AGrant or award
Restricted Stock Unitsderivative
+21,308$0.00$021,308Aug 11, 2025
May 12, 2025Thomas Edward Adams
Chief Financial Officer
AGrant or award
Restricted Stock Unitsderivative
+32,773$0.00$032,773Aug 11, 2025
May 12, 2025Linda M Tharby
President and CEO
AGrant or award
Option to buy Common Stockderivative
+94,772$0.00$094,772Aug 11, 2025
May 12, 2025Christopher Pazdan
Chief Operating Officer
AGrant or award
Option to buy Common Stockderivative
+36,077$0.00$036,077Aug 11, 2025
May 12, 2025Thomas Edward Adams
Chief Financial Officer
AGrant or award
Option to buy Common Stockderivative
+55,583$0.00$055,583Aug 11, 2025
Jul 2, 2025Donna French
director
AGrant or award
Common Stock
+4,189$33.58$141k84,974Jul 2, 2025
Jul 2, 2025Robert Cascella
director
AGrant or award
Common Stock
+4,189$3.58$15k84,615Jul 2, 2025
Jun 30, 2025Joseph M. Manko Jr.
director, owner
AGrant or award
Common Stockindirect: By Horton Capital Partners Fund, LP
+4,189$0.00$05,867,419Jul 2, 2025
Jul 2, 2025Edward Wholihan
director
AGrant or award
Common Stock
+4,189$3.58$15k37,772Jul 2, 2025
Jul 2, 2025Shahriar Matin
director
AGrant or award
Common Stock
+4,189$3.58$15k87,604Jul 2, 2025
Jul 2, 2025R John Fletcher
director, other
AGrant or award
Common Stock
+6,284$3.58$22k211,846Jul 2, 2025
May 20, 2025Joseph M. Manko Jr.
director, owner
JOther
Common Stockindirect: By Horton Capital Partners Fund, LP
-14,317$0.00$05,863,230May 22, 2025
Apr 21, 2025Linda M Tharby
Chief Executive Officer
FTax withholding
Common Stock
-23,587$2.20$52k1,023,163Apr 23, 2025
Mar 31, 2025Joseph M. Manko Jr.
director, owner
AGrant or award
Common Stockindirect: By Horton Capital Partners Fund, LP
+5,870$0.00$05,877,547Apr 2, 2025
Apr 2, 2025Edward Wholihan
director
AGrant or award
Common Stock
+5,870$2.56$15k33,583Apr 2, 2025
Apr 2, 2025Shahriar Matin
director
AGrant or award
Common Stock
+5,870$2.56$15k83,415Apr 2, 2025
Apr 2, 2025R John Fletcher
director, other
AGrant or award
Common Stock
+8,806$2.56$23k205,562Apr 2, 2025
Apr 2, 2025Robert Cascella
director
AGrant or award
Common Stock
+5,870$2.56$15k80,426Apr 2, 2025
Apr 2, 2025Donna French
director
AGrant or award
Common Stock
+5,870$2.56$15k80,785Apr 2, 2025
Mar 17, 2025Linda M Tharby
Chief Executive Officer
MOption exercise
Common Stock
+15,968$0.00$01,085,411Mar 21, 2025
Mar 17, 2025Christopher Pazdan
Chief Operating Officer
MOption exercise
Common Stock
+5,063--49,784Mar 21, 2025
Mar 17, 2025Thomas Edward Adams
Chief Financial Officer
MOption exercise
Common Stock
+5,404$0.00$05,404Mar 21, 2025
Mar 17, 2025Kenneth E Miller
Chief Commercial Officer
MOption exercise
Common Stock
+5,893$0.00$05,893Mar 21, 2025
Mar 17, 2025Linda M Tharby
Chief Executive Officer
FTax withholding
Common Stock
-8,848$2.89$26k1,076,563Mar 21, 2025
Mar 17, 2025Christopher Pazdan
Chief Operating Officer
FTax withholding
Common Stock
-1,641$2.89$4,73848,143Mar 21, 2025
Mar 17, 2025Kenneth E Miller
Chief Commercial Officer
FTax withholding
Common Stock
-2,168$2.89$6,2593,725Mar 21, 2025
Mar 17, 2025Thomas Edward Adams
Chief Financial Officer
FTax withholding
Common Stock
-1,988$2.89$5,7393,416Mar 21, 2025
Mar 17, 2025Thomas Edward Adams
Chief Financial Officer
MOption exercise
Restricted Stock Unitderivative
-5,404--16,212Mar 21, 2025
Mar 17, 2025Kenneth E Miller
Chief Commercial Officer
MOption exercise
Restricted Stock Unitderivative
-5,893--17,679Mar 21, 2025
Mar 19, 2025Linda M Tharby
Chief Executive Officer
FTax withholding
Common Stock
-29,813$2.83$84k1,046,750Mar 21, 2025
Mar 19, 2025Christopher Pazdan
Chief Operating Officer
MOption exercise
Common Stock
+36,331--84,474Mar 21, 2025
Mar 17, 2025Linda M Tharby
Chief Executive Officer
MOption exercise
Restricted Stock Unitderivative
-15,968--47,904Mar 21, 2025
Mar 19, 2025Christopher Pazdan
Chief Operating Officer
FTax withholding
Common Stock
-12,849$2.83$36k71,625Mar 21, 2025
Mar 17, 2025Christopher Pazdan
Chief Operating Officer
MOption exercise
Restricted Stock Unitsderivative
-5,063--15,192Mar 21, 2025
Mar 19, 2025Christopher Pazdan
Chief Operating Officer
MOption exercise
Performance Share Unitderivative
-36,331--0Mar 21, 2025
Feb 6, 2025Joseph M. Manko Jr.
director, owner
JOther
Common Stockindirect: By Horton Capital Partners Fund, LP
-16,187$0.00$05,871,677Feb 7, 2025
Jan 21, 2025Joseph M. Manko Jr.
director, owner
JOther
Common Stockindirect: By Horton Capital Partners Fund, LP
-1,000,000$0.00$05,887,864Jan 21, 2025
Jan 21, 2025Joseph M. Manko Jr.
director, owner
JOther
Common Stockindirect: By Horton Capital Partners, LLC
+1,000,000$0.00$01,000,000Jan 21, 2025
Jan 21, 2025Joseph M. Manko Jr.
director, owner
JOther
Common Stockindirect: By Horton Capital Partners, LLC
-1,000,000$0.00$00Jan 21, 2025
Jan 21, 2025Joseph M. Manko Jr.
director, owner
JOther
Common Stock
+351,948$0.00$0517,200Jan 21, 2025
Jan 3, 2025Robert Cascella
director
AGrant or award
Common Stock
+3,937$3.81$15k74,556Jan 3, 2025
Jan 3, 2025R John Fletcher
director, other
AGrant or award
Common Stock
+5,905$3.81$22k196,756Jan 3, 2025
Jan 3, 2025Donna French
director
AGrant or award
Common Stock
+3,937$3.81$15k74,915Jan 3, 2025
Jan 3, 2025Shahriar Matin
director
AGrant or award
Common Stock
+3,937$3.81$15k77,545Jan 3, 2025
Jan 3, 2025Edward Wholihan
director
AGrant or award
Common Stock
+3,937$3.81$15k27,713Jan 3, 2025
Dec 31, 2024Joseph M. Manko Jr.
director, owner
AGrant or award
Common Stockindirect: By Horton Capital Partners Fund, LP
+3,937$0.00$06,887,864Jan 3, 2025

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

KRMD insider trading: KORU Medical Systems, Inc. | InsiderTell